A Proof of Concept Trial of NM 505 in Patients with Type 2 Diabetes

Trial Profile

A Proof of Concept Trial of NM 505 in Patients with Type 2 Diabetes

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs NM 505 (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 09 Jun 2015 Positive clinical data were presented at the 75th Scientific Sessions of the American Diabetes Association, according to a MicroBiome Therapeutics media release.
    • 07 Apr 2015 According to a MicroBiome Therapeutics media release, results of this trial were published in the Journal of Diabetes Science and Technology.
    • 16 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top